138 related articles for article (PubMed ID: 13453515)
1. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
[No Abstract] [Full Text] [Related]
2. Interaction of convertin with platelets and with platelet-free and hemophilic plasma.
DE VRIES A; KREJNIS E; SHAFRIR E
Acta Haematol; 1956 Sep; 16(3):204-13. PubMed ID: 13354260
[No Abstract] [Full Text] [Related]
3. Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
JOHNSON JF; MAMMEN EF; SEEGERS WH
Thromb Diath Haemorrh; 1959 Sep; 3():588-92. PubMed ID: 14407473
[No Abstract] [Full Text] [Related]
4. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
[No Abstract] [Full Text] [Related]
5. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
[No Abstract] [Full Text] [Related]
6. Serum accelerator factors and antihemophilic factor (AHF) in early phases of clotting.
GRAHAM JB; LANGDELL RD; MORRISON FC; BRINKHOUS KM
Proc Soc Exp Biol Med; 1954 Oct; 87(1):45-8. PubMed ID: 13224672
[No Abstract] [Full Text] [Related]
7. Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease.
Bouma BN; Hordijk-Hos JM; DeGraaf S; Sixma JJ; Van Mourik JA
Nature; 1975 Oct; 257(5526):510-12. PubMed ID: 1080838
[TBL] [Abstract][Full Text] [Related]
8. The significance of abnormal preoperative hemostatic tests.
Bowie EJ; Owen CA
Prog Hemost Thromb; 1980; 5():179-209. PubMed ID: 6775346
[No Abstract] [Full Text] [Related]
9. Thrombelastographic observations on the characteristics of hemophilic, thrombocytopenic and heparinized blood.
DE NICOLA P; MAZZETTI GM
Blood; 1956 Jan; 11(1):71-80. PubMed ID: 13276486
[No Abstract] [Full Text] [Related]
10. Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.
Brinkhous KM; Graham JE; Cooper HA; Allain JP; Wagner RH
Thromb Res; 1975 Mar; 6(3):267-72. PubMed ID: 1078735
[No Abstract] [Full Text] [Related]
11. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY.
HARDISTY RM; HUTTON RA
Br J Haematol; 1965 May; 11():258-68. PubMed ID: 14282063
[No Abstract] [Full Text] [Related]
12. Bleeding time after aspirin in disorders of intrinsic clotting.
Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
[No Abstract] [Full Text] [Related]
13. Factor VIII-related activities in normal, haemophilic and von Willebrand's disease platelet fractions.
Meucci P; Peake IR; Bloom AL
Thromb Haemost; 1978 Oct; 40(2):288-301. PubMed ID: 310585
[No Abstract] [Full Text] [Related]
14. Factor VIII/von Willebrand factor.
Zimmerman TS; Ruggeri ZM; Fulcher CA
Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
[No Abstract] [Full Text] [Related]
15. The mode of action and aetiology of antihaemophilic globulin inhibitors.
BIGGS R; BIDWELL E; MACFARLANE RG
Sang; 1959; 30():340-51. PubMed ID: 13800639
[No Abstract] [Full Text] [Related]
16. Studies on factor VIII activation potential in hemophilia A-plasma and its significance for the comprehension of hemophilia.
Mingers AM
Eur J Pediatr; 1976 Oct; 123(3):187-98. PubMed ID: 1086208
[TBL] [Abstract][Full Text] [Related]
17. Studies on the Factor VIII/von Willebrand factor antigen on human platelets.
Coller BS; Hirschman RJ; Gralnick HR
Thromb Res; 1975 Jun; 6(6):469-80. PubMed ID: 1098217
[No Abstract] [Full Text] [Related]
18. A method for the study of antihaemophilic globulin inhibitors with reference to six cases.
BIGGS R; BIDWELL E
Br J Haematol; 1959 Oct; 5():379-95. PubMed ID: 13800640
[No Abstract] [Full Text] [Related]
19. Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
Brinkhous KM; Sandberg H; Garris JB; Mattsson C; Palm M; Griggs T; Read MS
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8752-6. PubMed ID: 3936044
[TBL] [Abstract][Full Text] [Related]
20. [Factor VIII (anti-hemophilic A factor). Biology, physiology, pathology and genetics].
Meyer D; Dray L; Allain JP; Larrieu MJ
Pathol Biol (Paris); 1972; 20(11):607-23. PubMed ID: 4558579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
